Innovair (Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous)

Formoterol stimulates β2‑adrenergic receptors on airway smooth muscle, causing rapid relaxation and bronchodilation. Beclometasone binds glucocorticoid receptors, altering gene expression to suppress inflammatory mediators, reduce airway swelling, and prevent mucus overproduction. Together they provide both immediate and long‑term control of airway narrowing.

The prescribed dose of Innovair is determined by the treating physician based on the patient’s age, severity of disease, and response to therapy. Patients should follow the specific inhalation instructions provided by their healthcare professional and never adjust the dose without medical guidance.

Safety data for Innovair in pregnancy and lactation are limited. The decision to use the inhaler should be made by a qualified healthcare provider after weighing the potential benefits for the mother against any possible risks to the fetus or infant.

To request Innovair, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Innovair offers a convenient single‑inhaler solution that combines an inhaled corticosteroid and a long‑acting β2‑agonist, reducing the need for multiple devices. Compared with separate inhalers, it may improve adherence and simplify dosing, while delivering comparable efficacy to other approved ICS/LABA combinations.

Innovair should be stored at room temperature below 25 °C, protected from moisture and direct sunlight. Keep the inhaler in its original packaging until use, and avoid exposing it to extreme heat or freezing conditions to maintain dose integrity.

Innovair is delivered via a metered‑dose inhaler. Patients should shake the device, prime it according to the manufacturer’s instructions, exhale fully, then inhale slowly and deeply while actuating the inhaler. A breath‑hold for about 10 seconds after inhalation helps maximize drug deposition.

Serious risks include paradoxical bronchospasm, severe allergic reactions such as anaphylaxis, and cardiovascular effects like tachycardia or palpitations. Patients should seek immediate medical attention if they experience sudden worsening of breathing, throat swelling, rash, or rapid heartbeat after using the inhaler.

Innovair is contraindicated in patients with a known hypersensitivity to either formoterol, beclometasone, or any excipients in the formulation. It should also be avoided in individuals who have experienced a severe paradoxical bronchospasm with a similar medication.